Italy

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076, currently in phase i clinical development

Menarini Ricerche today announced the publication of the results of a non-clinical study...

Menarini: Elcin Barker Ergun Group CEO

The Board of Directors has appointed Mrs. Elcin Barker Ergun  as CEO of Menarini Group.

First67891011121315

Our values

4 values, which have given life to Menarini and shaped its history

READ MORE »